Skip to main content
Equibles

206A · 株式会社PRISM BioLab · Financials

Use 206A with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research 206A.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
107 JPY +3 (+2.88%) At close · Nov 11
Rebalance outlook locked
Market Cap
3.96B JPY
Shares
36.96M
Volume · Nov 11 87.3K Avg daily vol (3M) 100.89K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
677.33M +121.6%
FY2025 Revenue FY2024–FY2025
Net Income
-833.7M +20.6%
FY2025 Net Income FY2024–FY2025
Gross Margin
39.83% -12.7pp
FY2025 Gross Margin FY2024–FY2025
Operating Margin
-114.34% +141.7pp
FY2025 Operating Margin FY2024–FY2025
Operating Cash Flow
-1.47B -1078%
FY2025 Operating Cash Flow FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024
JPY 677.33M 305.62M
JPY 407.57M 145.08M
JPY 269.76M 160.54M
JPY -774.45M -782.39M
JPY -831.28M -1.05B
JPY 2.42M 1.31M
JPY -833.7M -1.05B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.